Filtered By:
Vaccination: Meningitis Vaccine
This page shows you your search results in order of relevance. This is page number 6.
Order by Relevance | Date
Total 126 results found since Jan 2013.
A case series evaluating the serological response of adult asthma patients to the 23-valent pneumococcal polysaccharide vaccine
Asthma is an independent risk factor for invasive pneumococcal disease; however, the immune response of adult asthma patients to pneumococcal vaccination is unknown. We explore the serologic response of patien...
Source: Allergy, Asthma and Clinical Immunology - June 7, 2017 Category: Allergy & Immunology Authors: C. R. Laratta, K. Williams, D. Vethanayagam, M. Ulanova and H. Vliagoftis Source Type: research
Pneumococcal Vaccine for Only Half With Work - Related Asthma
54 percent of adults with work - related asthma, 35 percent with non - work - related asthma vaccinated
Source: Pulmonary Medicine News - Doctors Lounge - September 28, 2017 Category: Respiratory Medicine Tags: Family Medicine, Infections, Internal Medicine, Allergy, Nursing, Pathology, Pharmacy, Pulmonology, Journal, Source Type: news
P379 Getting with the guidelines: a primary care approach to improving pneumococcal vaccine administration
Streptococcal pneumonia is the most common cause of pneumonia and the leading agent causing hospitalization from bacteremia in adults. Vaccines containing the antigens of these surface polysaccharides are the primary means by which providers attempt to prevent or minimize the severity of streptococcal infections. Pneumonia remains a significant burden in the United making it important that we are aware of our current rate of appropriate vaccine administration.
Source: Annals of Allergy, Asthma and Immunology - October 27, 2017 Category: Allergy & Immunology Authors: R. D'Mello, P. Sandhu Source Type: research
P283 Pneumococcal osteomyelitis: a rare diagnosis suggestive of immune deficiency
Despite routine immunization with pneumococcal conjugate vaccines, Streptococcus pneumoniae is still a significant cause of bacteremia, pneumonia and meningitis. Osteoarticular pneumococcal infections are very rare, accounting for less than 5% of all invasive pneumococcal diseases (IPD).
Source: Annals of Allergy, Asthma and Immunology - October 27, 2017 Category: Allergy & Immunology Authors: T. Peng, M. Garcia-Lloret Source Type: research
P041 Successful administration of MenB-4C vaccine in the setting of an adverse reaction to MenB-FHbp
Two serogroup B meningococcal (MenB) vaccines, MenB-FHbp and MenB-4C, are available for use in persons aged 10-25 years in the United States. The Advisory Committee on Immunization Practices (ACIP) recommends either three-dose series of MenB-FHbp or two-dose series of MenB-4C. Adverse reactions like anaphylaxis have been infrequently reported.
Source: Annals of Allergy, Asthma and Immunology - October 27, 2017 Category: Allergy & Immunology Authors: R. Kuriakose, C. Patel, B. Kaplan Source Type: research
OR093 Evaluating pneumococcal vaccination status, patient demographics and disease burden at an Internal Medicine clinic
Pneumococcal illnesses are the cause of most frequently preventable diseases. A large number of patients are admitted for community acquired pneumonia (CAP) every month leading to prolonged hospitalizations and mortality. In this project, the relationship between pneumococcal vaccination status, patient demographics and their disease status was explored.
Source: Annals of Allergy, Asthma and Immunology - October 27, 2017 Category: Allergy & Immunology Authors: P. Sandhu, R. D'Mello, E. Abou-Jaoude Source Type: research
Transcutaneous immunization with pneumococcal surface protein A in mice
ConclusionThese results show that TCI with PspA plus CT induces antigen‐specific mucosal and systemic immune responses. This suggests that this method is an effective mucosal immunization strategy for induction of protective pneumococcal‐specific Ab responses in blockade of S. pneumoniae colonization of the nasal cavity.
Level of EvidenceNA. Laryngoscope, 2017
Source: The Laryngoscope - December 11, 2017 Category: ENT & OMF Authors: Hiromi Nagano, Masaki Kawabata, Gen Sugita, Akitoshi Tsuruhara, Junichiro Ohori, Tomohiro Jimura, Keiichi Miyashita, Yuichi Kurono, Kazuhiro Tomonaga, David E. Briles, Kohtaro Fujihashi Tags: Allergy/Rhinology Source Type: research
Late presentation of subtotal C6 deficiency in a patient with recurrent Neisseria meningitides infections
The complement system is important in fighting meningococcal disease. Recurrent meningococcal infections are a significant feature of terminal complement deficiency.1 The terminal complement system produces a membrane attack complex (MAC), which creates pores in bacteria, leading to lysis of microorganisms. Most invasive meningococcal infections are caused by Neisseria serotypes A, B, C, W-135, and Y, all of which are targeted with commercially available vaccines. Infections with less common serotypes are seen in patients with terminal complement deficiencies.
Source: Annals of Allergy, Asthma and Immunology - April 1, 2018 Category: Allergy & Immunology Authors: Lana Rosenfield, Anna Cvetkovic, Kevin Woodward, Jaclyn Quirt Source Type: research
A new diagnosis of cvid in a pediatric patient presenting with streptococcus pneumoniae meningitis
Common Variable Immune Deficiency (CVID) can present with a range of organ system involvement, including normal number of B-cells but decreased IgG, eventual decline in IgA and/or IgM, and poor/absent response to vaccinations.
Source: Annals of Allergy, Asthma and Immunology - November 1, 2018 Category: Allergy & Immunology Authors: K. Schissler, C. Ortega, V. Hernandez-Trujillo, J. Calderon Tags: M273 Source Type: research
Interlaboratory variability in multiplexed pneumococcal antibody testing
Assays that measure levels of IgG antibodies against specific serotypes of Streptococcus pneumoniae were initially developed and subsequently refined primarily for evaluation of vaccine efficacy.1 Because polysaccharide vaccines represent a well-defined immunogenic stimulus, measurement of serotype-specific antibody production in response to vaccination with the pneumococcal polysaccharide vaccine (PPV23) has also been used to evaluate humoral immune function in cases of suspected primary immune deficiency disease (PIDD).
Source: Journal of Allergy and Clinical Immunology - November 20, 2018 Category: Allergy & Immunology Authors: David C. LaFon, Moon H. Nahm Tags: Letter to the Editor Source Type: research
Effect of pneumococcal conjugate vaccine introduction on childhood pneumonia mortality in Brazil: a retrospective observational study
Publication date: February 2019Source: The Lancet Global Health, Volume 7, Issue 2Author(s): Cynthia Schuck-Paim, Robert J Taylor, Wladimir J Alonso, Daniel M Weinberger, Lone SimonsenSummaryBackgroundUnderstanding the real-world effect of pneumococcal conjugate vaccines (PCVs) on pneumonia mortality is crucial because of the expectation that increased PCV use will substantially reduce the burden of pneumonia deaths in children younger than 5 years. However, few post-vaccine introduction studies have estimated the benefits of PCV use on childhood mortality and results have been inconsistent. Therefore, we set out to assess...
Source: The Lancet Global Health - January 24, 2019 Category: International Medicine & Public Health Source Type: research
Every Breath You Take – Improving Asthma Wellness
Good control of asthma reduces related deaths and costs. The CDC recommends pneumococcal vaccination for patients with asthma, aged 18-64 years. Guidelines recommend assessment and documentation of asthma severity at each clinic visit. Objectives were to determine whether specific interventions would improve rates of pneumococcal vaccination and asthma severity documentation in asthma patients.
Source: Journal of Allergy and Clinical Immunology - February 1, 2019 Category: Allergy & Immunology Authors: Aparna S. Daley Source Type: research
Predicting Patient Response To Pneumococcal 23-vaccine (PPV23) Using Age, Baseline Immunoglobulins, and Pneumococcal Serotypes
The pneumococcal polysaccharide 23-serotype vaccine (PPV23) is an integral part of the evaluation and diagnosis of humoral antibody deficiencies. Although there are guidelines on how to interpret overall vaccine responses, there is a paucity of evidence on the significance of individual serotypes as possible predictors of immunodeficiency or future risk of immunodeficiency.
Source: Journal of Allergy and Clinical Immunology - February 1, 2019 Category: Allergy & Immunology Authors: Rayna J. Doll, David McGarry, Nancy Joseph, Jack Jeskey, Linda Quinn, Devi Jhaveri, Haig Tcheurekdjian, Robert W. Hostoffer Source Type: research
B Cell Reconstitution and Influencing Factors After Hematopoietic Stem Cell Transplantation in Children
Nicolaas G. van der Maas, Dagmar Berghuis, Mirjam van der Burg and Arjan C. Lankester*
Willem-Alexander Children's Hospital, Department of Pediatrics and Laboratory for Pediatric Immunology, Leiden University Medical Center, Leiden, Netherlands
B cell reconstitution after hematopoietic stem cell transplantation (HSCT) is variable and influenced by different patient, donor, and treatment related factors. In this review we describe B cell reconstitution after pediatric allogeneic HST, including the kinetics of reconstitution of the different B cell subsets and the development of the B cell repertoire, and d...
Source: Frontiers in Immunology - April 11, 2019 Category: Allergy & Immunology Source Type: research
